Search

for
Search:

GlossaryLiraglutide (Saxenda)

medication mimicking GLP-1 hormone to regulate blood sugar

Liraglutide is a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1) to help regulate blood sugar levels and appetite. It is commonly used to treat type 2 diabetes under the brand name Victoza and for weight management under the brand name Saxenda.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 369 results

A 12-Week Treatment with the Long-Acting Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Leads to Significant Weight Loss in a Subset of Obese Women with Newly Diagnosed Polycystic Ovary Syndrome

research A 12-Week Treatment with the Long-Acting Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Leads to Significant Weight Loss in a Subset of Obese Women with Newly Diagnosed Polycystic Ovary Syndrome

61 citations, January 2015 in “Hormones”

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Risk of Suicide, Hair Loss, and Aspiration with Glucagon-Like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS Database

research Risk of Suicide, Hair Loss, and Aspiration with Glucagon-Like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS Database

November 2024 in “Circulation”

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome

View more "saxenda" in research →

Community Join